Literature DB >> 23979825

Angioedema with normal laboratory values: the next step.

Janelle Sher1, Mark Davis-Lorton.   

Abstract

When faced with a patient with recurrent swelling, a thorough laboratory evaluation to determine the underlying etiology ensues. When the laboratory work-up is unrevealing, health care practitioners are frequently left in a quandary. This review will attempt to provide up-to-date information on how to approach the diagnosis and management of angioedema in a patient with normal laboratory values. The subtypes that will be reviewed in detail include: hereditary angioedema with normal C1 inhibitor (HAE with normal C1INH), drug-induced angioedema, and idiopathic angioedema. We present literature to aid the physician in the diagnosis and treatment of these disorders.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23979825     DOI: 10.1007/s11882-013-0383-7

Source DB:  PubMed          Journal:  Curr Allergy Asthma Rep        ISSN: 1529-7322            Impact factor:   4.806


  59 in total

1.  C1 esterase inhibitor in pregnancy.

Authors:  A J Cohen; C Laskin; S Tarlo
Journal:  J Allergy Clin Immunol       Date:  1992-09       Impact factor: 10.793

Review 2.  Anaphylactic and anaphylactoid causes of angioedema.

Authors:  Paul A Greenberger
Journal:  Immunol Allergy Clin North Am       Date:  2006-11       Impact factor: 3.479

3.  A case of hereditary angio-oedema type III presenting with C1-inhibitor cleavage and a missense mutation in the F12 gene.

Authors:  L Bouillet; D Ponard; H Rousset; S Cichon; C Drouet
Journal:  Br J Dermatol       Date:  2007-03-23       Impact factor: 9.302

Review 4.  Angioedema induced by angiotensin-converting enzyme inhibitors.

Authors:  Paloma Campo; Tahía D Fernandez; Gabriela Canto; Cristobalina Mayorga
Journal:  Curr Opin Allergy Clin Immunol       Date:  2013-08

5.  Missense mutation Thr309Lys in the coagulation factor XII gene in a Spanish family with hereditary angioedema type III.

Authors:  A Prieto; P Tornero; M Rubio; E Fernández-Cruz; C Rodriguez-Sainz
Journal:  Allergy       Date:  2009-02       Impact factor: 13.146

6.  Multicenter study of patients with angiotensin-converting enzyme inhibitor-induced angioedema who present to the emergency department.

Authors:  Aleena Banerji; Sunday Clark; Michelle Blanda; Frank LoVecchio; Brian Snyder; Carlos A Camargo
Journal:  Ann Allergy Asthma Immunol       Date:  2008-04       Impact factor: 6.347

7.  Hereditary angioedema with normal C1 inhibitor: clinical symptoms and course.

Authors:  Konrad Bork; Döndü Gül; Jochen Hardt; Georg Dewald
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

8.  Hereditary angioedema with normal C1 inhibitor function: consensus of an international expert panel.

Authors:  Bruce L Zuraw; Konrad Bork; Karen E Binkley; Aleena Banerji; Sandra C Christiansen; Anthony Castaldo; Allen Kaplan; Marc Riedl; Charles Kirkpatrick; Markus Magerl; Christian Drouet; Marco Cicardi
Journal:  Allergy Asthma Proc       Date:  2012 Nov-Dec       Impact factor: 2.587

9.  Diagnosis and treatment of hereditary angioedema with normal C1 inhibitor.

Authors:  Konrad Bork
Journal:  Allergy Asthma Clin Immunol       Date:  2010-07-28       Impact factor: 3.406

10.  Angioedema.

Authors:  Allen P Kaplan
Journal:  World Allergy Organ J       Date:  2008-06       Impact factor: 4.084

View more
  2 in total

1.  Hereditary angioedema with normal C1 inhibitor in a French cohort: Clinical characteristics and response to treatment with icatibant.

Authors:  Laurence Bouillet; Isabelle Boccon-Gibod; David Launay; Anne Gompel; Gisele Kanny; Vincent Fabien; Oliver Fain
Journal:  Immun Inflamm Dis       Date:  2017-01-11

2.  Phenotype standardization of angioedema in the head and neck region caused by agents acting on the angiotensin system.

Authors:  M Wadelius; S E Marshall; G Islander; L Nordang; M Karawajczyk; Q-Y Yue; I Terreehorst; E V Baranova; S Hugosson; K Sköldefors; M Pirmohamed; A-H Maitland-van der Zee; A Alfirevic; P Hallberg; C N A Palmer
Journal:  Clin Pharmacol Ther       Date:  2014-06-24       Impact factor: 6.875

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.